Specific thiazolidinediones inhibit ovarian cancer cell line proliferation and cause cell cycle arrest in a PPARγ independent manner.
about
Functions of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) in Gynecologic DisordersIn vitro and in vivo cytotoxicity of troglitazone in pancreatic cancerRepression of phosphoinositide-dependent protein kinase 1 expression by ciglitazone via Egr-1 represents a new approach for inhibition of lung cancer cell growthActivation of the PKC pathway stimulates ovarian cancer cell proliferation, migration, and expression of MMP7 and MMP10.The functional interaction between Acyl-CoA synthetase 4, 5-lipooxygenase and cyclooxygenase-2 controls tumor growth: a novel therapeutic target.Effects of PPARγ agonistrosiglitazone on human retinoblastoma cell in vitro and in vivo.New players for advanced prostate cancer and the rationalisation of insulin-sensitising medicationFatty Acids of CLA-Enriched Egg Yolks Can Induce Transcriptional Activation of Peroxisome Proliferator-Activated Receptors in MCF-7 Breast Cancer Cells.A new dawn for the use of thiazolidinediones in cancer therapy.Pioglitazone, a PPARγ agonist, inhibits growth and invasion of human hepatocellular carcinoma via blockade of the rage signaling.A novel melittin-MhIL-2 fusion protein inhibits the growth of human ovarian cancer SKOV3 cells in vitro and in vivo tumor growth.Peroxisome proliferator-activated receptors (PPARs) are potential drug targets for cancer therapyThe Role of PPARγ in the Transcriptional Control by Agonists and Antagonists.The PPARδ ligand L-165041 inhibits VEGF-induced angiogenesis, but the antiangiogenic effect is not related to PPARδ.
P2860
Q28082264-AEF67ABB-0FB8-407D-ABBB-618C515B5C89Q32174263-A4C6D612-0743-4DA3-8051-6DB5FA240BA3Q33770896-832F7DD2-73A3-4DCF-98C1-AB77C0575D03Q33888968-CDD05184-44C1-49A4-8723-3B1DA64F230DQ34342416-F4CE6F48-8BB9-4590-AC59-FF02BB5B2F38Q36375151-F9282449-EF11-4A33-8E25-3D9674399E0EQ36734036-14351C27-2761-42DD-B1D8-1375283A8594Q37742662-87785828-9F3F-4FA7-B8DD-5CF598D2BB40Q38193545-C9256DDA-390C-42C0-BA0D-DBA28683C530Q38948698-75AF33DD-9A2A-4EF3-8B7E-9F4D7BDD37B6Q39188053-8B9ED19F-FCCC-4BDB-8B25-32DB3A3021DBQ41694098-CB8748B2-1AE0-4BD7-93F7-50C0EE23B6CFQ42185295-3E5E8BF9-9F51-42E0-9549-6E376522E3F0Q53193081-88CD68B2-F4AB-4D5C-BF04-23091865B9B7
P2860
Specific thiazolidinediones inhibit ovarian cancer cell line proliferation and cause cell cycle arrest in a PPARγ independent manner.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Specific thiazolidinediones in ...... in a PPARγ independent manner.
@ast
Specific thiazolidinediones in ...... in a PPARγ independent manner.
@en
type
label
Specific thiazolidinediones in ...... in a PPARγ independent manner.
@ast
Specific thiazolidinediones in ...... in a PPARγ independent manner.
@en
prefLabel
Specific thiazolidinediones in ...... in a PPARγ independent manner.
@ast
Specific thiazolidinediones in ...... in a PPARγ independent manner.
@en
P2093
P2860
P1433
P1476
Specific thiazolidinediones in ...... in a PPARγ independent manner.
@en
P2093
Linah Al-Alem
Michael W Kilgore
R Chase Southard
Thomas E Curry
P2860
P304
P356
10.1371/JOURNAL.PONE.0016179
P407
P577
2011-01-21T00:00:00Z